Jean Marc Phelip (Jean-Marc Phelip)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Metastatic Colorectal Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jean Marc Phelip, David Malka
Reply to M. Salati et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (12) (2022)
Jean-Phillippe Metges, Dominique Genet, David Tougeron, Catherine Ligeza, Michel Ducreux, Christophe Borg, Rosine Guimbaud, Jean Marc Phelip, Louis-Marie Dourthe, Stefano Kim
Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort. Future oncology (London, England) 17 (25) (2021)
Laetitia Dahan, Nicolas Williet, Karine Le Malicot, Jean Marc Phelip, Jérôme Desrame, Olivier Bouché, Caroline Petorin, David Malka, Christine Rebischung, Thomas Aparicio, Cédric Lecaille, Yves Rinaldi, Anthony Turpin, Anne-Laure Bignon, Jean-Baptiste Bachet, Jean-François Seitz, Côme Lepage, Eric François, null null
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (29) (2021)
Jean Marc Phelip, Jérôme Desrame, Julien Edeline, Emilie Barbier, Eric Terrebonne, Pierre Michel, Hervé Perrier, Laetitia Dahan, Vincent Bourgeois, Faiza Khemissa Akouz, Emilie Soularue, Valérie Lebrun Ly, Yann Molin, Thierry Lecomte, François Ghiringhelli, Romain Coriat, Samy Louafi, Cindy Neuzillet, Sylvain Manfredi, David Malka, null null
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)